Skip to content

Latest News

Budget 2023: Foreign pharma firms push for fast-tracking of new drug approvals, ease of doing business

Budget 2023: Foreign pharma firms push for fast-tracking of new drug approvals, ease of doing business

Multinational drugmakers are seeking relaxation of norms that govern the launch of new medicines and clinical trials of drugs in India. Read More ​ Multinational drugmakers are seeking relaxation of norms that govern the launch of new medicines and clinical trials of… Read More »Budget 2023: Foreign pharma firms push for fast-tracking of new drug approvals, ease of doing business

en_USEnglish